Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Pivotal Phase 1, Randomized, Single-Dose, 4-Period, Crossover Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine Under Fasted Conditions in Healthy Volunteers


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04767035

Organisation Name: Melt Pharmaceuticals

Overal Status: Completed

Start Date: December 1, 2020

Last Update: February 23, 2021

Lead Sponsor: Melt Pharmaceuticals

Brief Summary: A Pivotal Phase 1, Randomized, Single-Dose, 4-Period, Crossover Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine under Fasted Conditions in Healthy Volunteers

Conditions:
  • Procedural Sedation


Total execution time in seconds: 0.16472220420837